Macromolecular Proton Fraction as a New Clinical Biomarker of Demyelination in Multiple Sclerosis

Keywords

acquisition allowing appearing appropriate arises associations attracted audience automated averaging binary biophysical body brain capability class classes classified clinical coded commonly composed conservative considered consistently constraints content contributions controls correction correlation correlations correspond cortical coverage cross damage decrease described detection determining developed deviation disability disease dual duration either entire entirely equation examination example except expanded expected fall fast finding flair fraction functional gauss growing highlights highly hunter include industry invisible junction layer lesion lesions macromolecular magnetization male mapping maps mask masks model much neural neurological normalization nuclei observations outlined partial pathological patients population potential predict processing progression pronounced protocol proton providing pulsed quantitative radiologists radiology receive reconstruction relapsing reported respectively role saturation scale scales scanner sclerosis secondary segmentation segmented semi separately significantly since software source specificity status step straightforwardly stripped stronger strongest subjects suggested superficial systems table target technology tissue tissues traditionally transfer trials variables volume water weaker whole years yield